Effect of different dosage of progesterone on uterine and placental vascular resistance in women at risk of preterm birth
Design
Clinical trials with control group, with parallel groups, Non-random, single center trial. Sample size (3 groups of 30 control and intervention).
Settings and conduct
Amir Al-Momenin Hospital, Semnan.
All three groups will initially undergo color Doppler ultrasound of the uterine vessels, umbilical artery, and middle cerebral artery of the fetus.
In the first group 400 mg progesterone and in the second group 200 mg progesterone is given vaginally. and the third group is studied as a control group.
Participants/Inclusion and exclusion criteria
Pregnant women at risk of preterm birth.
Inclusion criteria: Singleton pregnancy; Pregnancy age 24 to 33 weeks.
Exclusion criteria: A history of intrauterine insemination (IUI); In vitro fertilization (IVF) history.
Intervention groups
Intervention group 1: In this group, a 400 mg progesterone suppository will be used vaginally according to the treatment protocol.
Intervention group 2: In this group, a 200 mg progesterone suppository will be used vaginally according to the treatment protocol.
Control group: Only for comparison with intervention group, no treatment is performed.